Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication

AIMS: Helicobacter pylori (Hp) eradication plays a key role in the treatment and prevention of peptic ulcer diseases. Increasing clarithromycin resistance in Hp necessitates more effective treatments for eradication, such as bismuth‐containing quadruple therapy. We aimed to compare the safety and ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Huh, Ki Young, Chung, Hyewon, Kim, Yu Kyong, Lee, SeungHwan, Bhatia, Siddharth, Takanami, Yohei, Nakaya, Ryou, Yu, Kyung‐Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291775/
https://www.ncbi.nlm.nih.gov/pubmed/34080718
http://dx.doi.org/10.1111/bcp.14934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291775/
https://www.ncbi.nlm.nih.gov/pubmed/34080718
http://dx.doi.org/10.1111/bcp.14934

Ejemplares similares